| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013785 |
| Receipt No. | R000015290 |
| Official scientific title of the study | Clinical trial on the efficacy and safety of robot assisted laparoscopic partial nephrectomy using Davinci surgical system |
| Date of disclosure of the study information | 2014/04/23 |
| Last modified on | 2016/05/31 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Clinical trial on the efficacy and safety of robot assisted laparoscopic partial nephrectomy using Davinci surgical system | |
| Title of the study (Brief title) | Clinical trial on the efficacy and safety of robot assisted laparoscopic partial nephrectomy using Davinci surgical system | |
| Region |
|
|
| Condition | ||
| Condition | renal tumor | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Clinical trial on the efficacy and safety of robot assisted laparoscopic partial nephrectomy using Davinci surgical system |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Efficacy and safety of robot assisted laparoscopic partial nephrectomy
(surgical margine negative,WIT<25min,no blood transfusion,no complication) |
| Key secondary outcomes | operative time, complication, pathology, prognosis |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | patient of renal cellcarcinoma | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | clinical stage T1aN0M0 | |||
| Key exclusion criteria | performance status 2
ASA 4 |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Tadashi Matsuda |
| Organization | Kansai medical university Hirakata hospital |
| Division name | urology |
| Address | 2-3-1 hirakata osaka |
| TEL | 072-804-0101 |
| matsudat@takii.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Motohiko Sugi |
| Organization | Kansai medical university Hirakata hospital |
| Division name | urology |
| Address | 2-3-1 hirakata osaka |
| TEL | 072-804-0101 |
| Homepage URL | |
| sugim@takii.kmu.ac.jp | |
| Sponsor | |
| Institute | the department of urology, kansai medical university |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | the department of urology, kansai medical university |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 関西医科大学 枚方病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015290 |